Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Clinical trial NCT05081193 · COMPLETED

Trial details

NCT number: NCT05081193
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2022-03-07
Primary completion: 2025-08-04
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.